Negative association between Catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia

被引:26
作者
Lai, IC
Wang, YC
Lin, CC
Bai, YM
Liao, DL
Yu, SC
Lin, CY
Chen, JY
Liou, YJ
机构
[1] Yuli Vet Hosp, Dept Psychiat, Yuli 981, Hualien, Taiwan
[2] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan
[3] Taipei Med Univ, Inst Clin Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan
[5] Pali PSychiat Ctr Hosp, Taipei, Taiwan
[6] Yuli Hosp, Dept Child Psychiat, Hualien, Taiwan
[7] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
关键词
Catechol-O-methyltransferase; COMT; tardive dyskinesia; polymorphism; association study; antipsychotics;
D O I
10.1007/s00702-004-0252-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic administration of typical antipsychotic agents, which mainly act on the dopamine receptors, implicates a role of dopamine system on the susceptibility of tardive dyskinesia (TD). In the present study, the association between a functional Val158Met polymorphism of Catechol-O-methyltransferase (COMT) gene and TD occurrence and TD severity was investigated in 299 Chinese schizophrenic patients with long-term antipsychotic treatment (TD: 166, non-TD: 133). After adjusting the effects of confounding factors, there was no significant association between COMT genotype and TD occurrence (p=0.367). Among TD patients, we found no significant correlation between COMT genotypes and the total scores of abnormal involuntary movement scale (AIMS) (p=0.629). We concluded that this COMT polymorphism might not play a major role in the susceptibility of TD nor on the severity of TD.
引用
收藏
页码:1107 / 1113
页数:7
相关论文
共 17 条
[1]   Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats - Implications for tardive dyskinesia? [J].
Andreassen, OA ;
Jorgensen, HA .
PROGRESS IN NEUROBIOLOGY, 2000, 61 (05) :525-541
[2]   Tardive dyskinesia and atypical antipsychotic drugs [J].
Casey, DE .
SCHIZOPHRENIA RESEARCH, 1999, 35 :S61-S66
[3]   Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia [J].
Chen, CH ;
Lee, YR ;
Wei, FC ;
Koong, FJ ;
Hwu, HG ;
Hsiao, KJ .
BIOLOGICAL PSYCHIATRY, 1997, 41 (09) :985-987
[4]   Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E [J].
Elkashef, AM ;
Wyatt, RJ .
SCHIZOPHRENIA BULLETIN, 1999, 25 (04) :731-740
[5]   Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene [J].
Hasan, HA ;
Erdal, ME ;
Böke, Ö ;
Savas, HA .
EUROPEAN PSYCHIATRY, 2003, 18 (02) :77-81
[6]   Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders [J].
Lachman, HM ;
Papolos, DF ;
Saito, T ;
Yu, YM ;
Szumlanski, CL ;
Weinshilboum, RM .
PHARMACOGENETICS, 1996, 6 (03) :243-250
[7]   Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism [J].
Lerer, B ;
Segman, RH ;
Fangerau, H ;
Daly, AK ;
Basile, VS ;
Cavallaro, R ;
Aschauer, HN ;
McCreadie, RG ;
Ohlraun, S ;
Ferrier, N ;
Masellis, M ;
Verga, M ;
Scharfetter, J ;
Rietschel, M ;
Lovlie, R ;
Levy, UH ;
Meltzer, HY ;
Kennedy, JL ;
Steen, VM ;
Macciardi, F .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (01) :105-119
[8]   Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan [J].
Liou, YJ ;
Tsai, SJ ;
Hong, CJ ;
Wang, YC ;
Lai, IC .
NEUROPSYCHOBIOLOGY, 2001, 43 (01) :11-14
[9]   KINETICS OF HUMAN SOLUBLE AND MEMBRANE-BOUND CATECHOL O-METHYLTRANSFERASE - A REVISED MECHANISM AND DESCRIPTION OF THE THERMOLABILE VARIANT OF THE ENZYME [J].
LOTTA, T ;
VIDGREN, J ;
TILGMANN, C ;
ULMANEN, I ;
MELEN, K ;
JULKUNEN, I ;
TASKINEN, J .
BIOCHEMISTRY, 1995, 34 (13) :4202-4210
[10]   Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia [J].
Matsumoto, C ;
Shinkai, T ;
Hori, H ;
Ohmori, O ;
Nakamura, J .
PSYCHIATRY RESEARCH, 2004, 127 (1-2) :1-7